NCT05615389: Pilot Study of MC in Paediatric Palliative Care

Summary

The goal of this pilot study is to explore the feasibility and acceptability of a medicinal cannabis clinical trial into easing the symptoms of children undergoing palliative care for non-oncological conditions. The trial will evaluate the study design including recruitment strategy, medication tolerability, duration and outcomes to determine acceptability and feasibility for participating families. The data collected will then be used to design a full-scale multi-centre trial. Participants will be randomly allocated to receive one of two medicinal cannabis products. Neither the participants nor researchers will know the study drug allocation until the end of the trial.

Timeline

Start: 2024-02-19
Primary completion: 2026-10
Completion: 2026-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	C12T12	Unknown	0.5 mg/kg	Oral
Subject	C20T5	Unknown	—	Oral

Indications

No indication recorded.